| Document |
Document Title |
|
WO/2021/162194A1 |
Provided are a novel peptide compound containing piperazic acid, and a stereoisomer, a solvate, or a pharmaceutically acceptable salt thereof; a method of producing same; and uses of same. The peptide compound, and the stereoisomer, solv...
|
|
WO/2021/159828A1 |
Provided are an enzyme having an acyl group transfer function as well as a mutant and application thereof, an amino acid sequence of the acyltransferase being that of SEQ ID NO: 1, and same being able to perform acylation on Macrolactins...
|
|
WO/2021/162226A1 |
The present invention relates to a Bacillus subtilis JCK-1398 strain (Accession No. KCTC 14084BP) having induced resistance activity in pine trees and various plants, a pesticidal or antibacterial composition comprising same as an active...
|
|
WO/2021/159923A1 |
A sinking-type Rhodosporidium sphaerocarpum microbial preparation, and a preparation method and a use therefor. The present microbial preparation comprises the following components in mass percent: 20-30% Rhodosporidium sphaerocarpum ZDF...
|
|
WO/2021/163148A1 |
The subject invention provides compositions and methods for reducing deleterious atmospheric gas emissions produced in livestock animals' digestive systems and/or waste. In preferred embodiments, a composition comprising one or more bene...
|
|
WO/2021/159220A1 |
The present invention relates to a biostimulant based on the bacterium Pseudomonas lini strain S57 RGM 2930 CChRGM for agricultural use, especially in saline-boric environments. The product can be developed as solid and/or liquid formula...
|
|
WO/2021/159886A1 |
Provided are an Ensifer sesbaniae Y5 strain and a use thereof in biological electricity production. The present strain is stored in the Guangdong Microbial Culture Collection Center and has an accession number of GDMCC No: 60957, and a d...
|
|
WO/2021/155728A1 |
Provided is a nucleic acid detection kit for novel coronavirus 2019-nCoV, and in particular, provided are a kit and a method for multiple detection of the nucleic acid of the novel coronavirus 2019-nCoV. Three nucleic acid targets of the...
|
|
WO/2021/157867A1 |
The present application relates to Lactobacillus sakei strain HEM224 (KCTC14065BP), and a composition for treating, preventing or alleviating inflammation or asthma, comprising the strain. Lactobacillus sakei strain HEM224 (KCTC14065BP) ...
|
|
WO/2021/158179A1 |
The present invention relates to a process of mycelial co-cultivation of Schizophyllum commune strain PLNP13 and Ganoderma lucidum strain LZ, and to the β-glucan obtained therefrom. The invention provides a β-1,6-branched-β-1,3-glucan...
|
|
WO/2021/155452A1 |
The present invention relates to an optimized process for producing ethanol from energy cane by integrating first-generation (1G) technology with second-generation (2G) technology, said optimized process having the advantage of reducing ...
|
|
WO/2021/151946A1 |
A composition comprising a bacterial strain of the species Enterococcus durans, for use in a method of treating or preventing a central nervous system disorder or condition.
|
|
WO/2021/148592A1 |
The present invention relates to the use of a defoaming agent for preventing pellet morphology of thermophilic fungi when grown at acidic pH in chemically defined media. The invention pertains to processes for producing a fermentation pr...
|
|
WO/2021/147874A1 |
Disclosed is a virus inhibiting Wnt signaling and a method for Wnt signaling using the virus. Also disclosed is a method for treating tumors using the virus.
|
|
WO/2021/148974A1 |
The present invention relates to two new strains of lactic acid bacteria, Lactobacillus brevis DSM 33325 and Lactobacillus plantarum DSM 33326, to a new food composition, and to the process for the preparation thereof.
|
|
WO/2021/147558A1 |
Provided are a nitrilase mutant and the use thereof in the preparation of an anti-epileptic drug intermediate. The mutant is obtained by means of mutating one or more of the amino acids at positions 151, 223 and 250 of the amino acid seq...
|
|
WO/2021/148575A1 |
The invention relates to a method for preparing a chitinase comprising composition by fermenting a bacteria strain which is capable of producing chitinase, which bacteria strain is immobilized on a carrier, wherein the carrier comprises ...
|
|
WO/2021/147260A1 |
Provided is an Alcaligenes faecalis strain capable of degrading ethylene oxide and uses thereof. The deposit number of the strain is CGMCC No. 18435. This strain can be used in pollution treatment, for example, to treat industrial sewage...
|
|
WO/2021/147261A1 |
Provided are strains for degrading ethylene oxide and degradation agents comprising the same, wherein the strains are Acetobacter peroxydans EO-01 strain with Deposit number of CGMCC No. 18431; Lactobacillus fermentum EO-02 strain with D...
|
|
WO/2021/149011A1 |
The object of the invention is a strain of unicellular red algae Cyanidioschyzon merolae, deposited on the 25th October 2019 in accordance with the requirements of The Budapest treaty in Banco Espaňol de Algas, Las Palmas, Spain under t...
|
|
WO/2021/148064A1 |
The present invention relates to a method of synthesis of a biodegradable polyurethane foam, comprising the following steps: i) mixing of at least one aliphatic isocyanate bearing at least two isocyanate groups with at least one sacchari...
|
|
WO/2021/147259A1 |
A Kurthia gibsonii strain EO-06 with Deposit Number of CGMCC No. 18436, a Clostridium kogasensis strain EO-08 with Deposit Number of CGMCC No. 18438 and a Clostridium acidisoli strain EO-09 with Deposit Number of CGMCC No. 18439 are prov...
|
|
WO/2021/147293A1 |
Provided is Stenotrophomonas maltophilia GYH and an application thereof in degradation of chlorinated hydrocarbon pollutants. In the application, resting cells obtained by expansion culture of Stenotrophomonas maltophilia GYH are added i...
|
|
WO/2021/147900A1 |
The present disclosure relates to a use of Nocardia rubra cell wall skeleton in regenerative medicine, and in particular, to a use of Nocardia rubra (especially the cell wall skeleton thereof) in the following aspects: promoting prolifer...
|
|
WO/2021/150450A1 |
A bioreactor includes a first compartment designed to retain seaweed sporophytes, a second compartment in fluid communication with the first compartment that includes one or more settlement surfaces, and a first porous barrier between th...
|
|
WO/2021/143858A1 |
Antibodies and antigen-binding fragments thereof that bind to human NKp30, multispecific antibodies that recognize NKp30 as one antigen and at least one other antigen, a pharmaceutical composition comprising NKp30 antibodies, and use of ...
|
|
WO/2021/143037A1 |
Lactobacillus acidipiscis, fermented soymilk, preparation methods therefor and uses thereof. The preservation number of the Lactobacillus acidipiscis HAU-FR7 is CGMCC NO.19253. The Lactobacillus acidipiscis HAU-FR7 is a facultative anaer...
|
|
WO/2021/143727A1 |
Provided are a Corynebacterium glutamicum that produces L-lysine, a method for constructing the L-lysine-producing bacterium, and a method for preparing L-lysine using the bacterium. The lysine yield and glucose conversion rate are impro...
|
|
WO/2021/146411A1 |
The present disclosure is generally related to compositions and methods for constructing and/or obtaining B. licheniformis cells (e.g., protein production hosts) comprising enhanced protein production capabilities. Thus, certain embodime...
|
|
WO/2021/146233A1 |
The present invention relates to a method for producing a recombinant protein in yeast cells, wherein the cells are subjected to a temperature shift at a specific timepoint of the cell culture. It also relates to a method for producing a...
|
|
WO/2021/143114A1 |
Provided are a recombinant collagen and a recombinant collagen sponge material. The recombinant collagen comprises (a) a protein consisting of an amino acid sequence shown in SEQ ID NO. 2, and/or (b) a protein derived from (a) by subject...
|
|
WO/2021/143356A1 |
Disclosed is a method for preparing L-2-aminobutyric acid by means of double enzyme series connection, relating to the field of bioengineering. By respectively culturing recombinant Escherichia coli expressing L-glutamate mutase and L-as...
|
|
WO/2021/142911A1 |
A vaccine strain screening method, comprising the following steps: separating and culturing strains to be screened; identifying whether the strains to be screened are vaccine strains of the desired species; identifying serotypes of the s...
|
|
WO/2021/143468A1 |
Provided are a carrier comprising a temperature switch loop and application thereof in increasing the yield of threonine in microbial cells. According to the carrier, heterologous expression of pyruvate carboxylase is controlled, tempera...
|
|
WO/2021/144172A1 |
The invention concerns new Bacillus strains which are able to degrade effectively inorganic nitrogen compounds and are further able to inhibit the growth of pathogens of aquatic animals.
|
|
WO/2021/143833A1 |
Provided are a high-yield eurotium cristatum strain containing a diketopiperazine dimer, a method for separating and purifying the diketopiperazine dimer therefrom, and a use of a diketopiperazine dimer in the preparation of a hypoglycem...
|
|
WO/2021/144473A2 |
The present invention relates to genetically modified gram-negative bacteria, in particular E. coli, that are oversensitive to lysis. These bacteria are therefore useful to improve the yield of nucleic acid extraction, preferably extra-g...
|
|
WO/2021/139170A1 |
A bok choy plasma membrane intrinsic aquaporin having an amino acid sequence as shown in SEQ ID NO. 2, and the nucleotide sequence of an encoding gene BraPIP1;1 thereof being as shown in SEQ ID NO. 1. The plasma membrane intrinsic aquapo...
|
|
WO/2021/138924A1 |
Provided is Bacillus methylotrophicus BP1.1. The strain was deposited in the China Center for Type Culture Collection on 20 December 2019, and the deposit number is CCTCC M 20191078. Further disclosed is an application of the described B...
|
|
WO/2021/140110A1 |
The technology provided herein relates to novel methods for producing lactic acid (L-lactic acid, D-lactic acid and D/L-Lactic acid) from starch containing material with extreme thermophilic bacterial cells belonging to the genus Caldice...
|
|
WO/2021/139895A1 |
The technology provided herein relates to novel methods for producing lactic acid (L-lactic acid, D-lactic acid and D/L-Lactic acid) from starch containing material with extreme thermophilic bacterial cells belonging to the genus Caldice...
|
|
WO/2021/141384A1 |
The present invention relates to a vaccine composition for preventing or treating porcine proliferative enteritis and salmonellosis simultaneously, containing an attenuated Salmonella mutant as an active ingredient, the attenuated Salmon...
|
|
WO/2021/141303A1 |
The present invention relates to a novel Bacillus velezensis WK2019 strain and a milk fermentate using same. More specifically, the Bacillus sp. Bacillus velezensis WK2019, which is isolated from kimchi, was found to allow the provision ...
|
|
WO/2021/140526A1 |
The present invention discloses mutant semi-synthetic β-lactam antibiotics synthesizing enzymes of penicillin G acylase from Achromobacter sp. CCM4824 generated by site directed mutations with substitution of one or more amino acid posi...
|
|
WO/2021/138799A1 |
Provided are an isolated or purified Trichoderma antagonistic representative gene and application, and a gene sequence-based Trichoderma antagonistic evaluation amplification primer and application. The isolated or purified Trichoderma a...
|
|
WO/2021/114029A9 |
Provided is a GAL gene regulation and control system. In the GAL gene regulation and control system, pCTR3 or pCTR1 is operably linked to the GAL80 gene; and pCUP1 is operably linked to the GAL4 gene. Also provided are a Saccharomyces ce...
|
|
WO/2021/134914A1 |
Provided are a Monascus purpureus (Monascus purpureus) strain and the use thereof in the preparation of a dairy product. The strain deposit number is CGMCC No.18564. Also provided is a method for preparing cheese from the Monascus purpur...
|
|
WO/2021/137602A1 |
The present invention relates to a novel Lactobacillus fermentum strain (accession number: KCTC 14106BP), and a composition for preventing or treating metabolic diseases, comprising same. Lactobacillus fermentum of the present invention ...
|
|
WO/2021/135597A1 |
The present application provides a method for preparing tinzaparin sodium; using heparin as a substrate, performing enzymolysis by heparinase I in a solvent to obtain tinzaparin sodium. The weight ratio of heparin to heparinase I is 1:(0...
|
|
WO/2021/135037A1 |
Provided are a device and method for separating and recovering the contents of the intestines. The separation and recovery device comprises an impurity removal module and a target contents collection module; the impurity removal module r...
|
